GlassScriptPhysician profile
Patricia Bedoya
NPI 1518257021
$2,231.68
in general payments reported to CMS, 2019-2025
18 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $375 · 2021: $124 · 2022: $116 · 2023: $297 · 2024: $707 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $456.51 | 2019-2025 | Collagenase Santyl, Oasis, Versajet |
| Kerecis Limited | $382.41 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Treace Medical Concepts, INC. | $243.42 | 2023-2024 | |
| Djo, LLC | $145.04 | 2020-2023 | Cmf |
| Acera Surgical, INC. | $137.53 | 2025 | Restrata Wound Matrix |
| Cardiovascular Systems INC. | $134.38 | 2020 | |
| Paratek Pharmaceuticals, INC. | $121.92 | 2023 | Nuzyra |
| Cook Medical LLC | $119.49 | 2020 | |
| Zimmer Biomet Holdings, INC. | $100.63 | 2019 | |
| Horizon Therapeutics Plc | $89.66 | 2021 | |
| Heron Therapeutics, INC. | $72.47 | 2022 | |
| Medtronic, INC. | $52.91 | 2023-2025 | Intellis Adaptivestim |
| Biotissue Holdings INC. | $47.16 | 2024 | |
| Wright Medical Technology, INC. | $38.50 | 2019 | |
| Averitas Pharma INC. | $34.56 | 2025 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $24.47 | 2019 | |
| Convatec INC. | $17.21 | 2023 | |
| Melinta Therapeutics, LLC | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Bedoya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.